Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1039/c5md00238a http://scihub22266oqcxt.onion/10.1039/c5md00238a C4756575!4756575 !26949507     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=26949507 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Medchemcomm 2015 ; 6 (8 ): 1420-1426 Nephropedia Template TP {{tp|p=26949507 |t=2015. The discovery of a novel antibiotic for the treatment of Clostridium difficile infections: a story of an effective academic-industrial partnership |pdf=|usr=}}{{26949507 }} gab.com Text The discovery of a novel antibiotic for the treatment of Clostridium difficile infections: a story of an effective academic-industrial partnership JO: Medchemcomm http://www.kidney.de/pget.php?&tw=1&pmid=26949507 #FOAvip Academic drug discovery is playing an increasingly important role in the identification of new therapies for a wide range of diseases. There is no one model that guarantees success. We describe here a drug discovery story where chance, the ability to capitalise on chance, and the assembling of a range of expertise, have all played important roles in the discovery and subsequent development of an antibiotic chemotype based on the bis-benzimidazole scaffold, with potency against a number of current therapeutically challenging diseases. One compound in this class, SMT19969, has recently entered Phase 2 human clinical trials for the treatment of Clostridium difficile infections. Twit Text FOAVip The discovery of a novel antibiotic for the treatment of Clostridium difficile infections: a story of an effective academic-industrial partnership ????Medchemcomm http://www.kidney.de/pget.php?&tw=1&pmid=26949507 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26949507 #FOAvip English Wikipedia <ref>{{Cite pmid|26949507 }}</ref> The discovery of a novel antibiotic for the treatment of Clostridium difficile infections: a story of an effective academic-industrial partnership #MMPMID26949507 Mann J ; Taylor PW ; Dorgan CR ; Johnson PD ; Wilson FX ; Vickers R ; Dale AG ; Neidle S Medchemcomm 2015[Aug]; 6 (8 ): 1420-1426 PMID26949507 show ga Academic drug discovery is playing an increasingly important role in the identification of new therapies for a wide range of diseases. There is no one model that guarantees success. We describe here a drug discovery story where chance, the ability to capitalise on chance, and the assembling of a range of expertise, have all played important roles in the discovery and subsequent development of an antibiotic chemotype based on the bis-benzimidazole scaffold, with potency against a number of current therapeutically challenging diseases. One compound in this class, SMT19969, has recently entered Phase 2 human clinical trials for the treatment of Clostridium difficile infections. ?The discovery of a novel antibiotic for the treatment of Clostridium d(epmc).pdf DeepDyve Pubget Overpricing